AcouSort AB and GenSensor SAS announced that the two companies have signed a Letter of Intent to integrate AcouSort?s acoustofluidics technology with GenSensor?s biology first Process Analytical Technology to accelerate bioprocess design and improve monitoring systems for bioreactor culturing. AcouSort and GenSensor share a common interest in providing the healthcare market with innovative solutions that improve production efficiency and the development of advanced therapeutics leading to better patient outcomes upon treatment. The GenSensor technology performs automated, self-adapting cell sampling from various kinds of bioreactors.

The solution also isolates and identifies biomarkers as well as perform bioinformatics analyses to document and optimize all kinds of bioprocesses from R&D and scale-up to routine production in order to increase bioproduction excellence and yield. AcouSort?s AcouTrap technology enables gentle and automated isolation and purification of cells from various samples starting materials or cultures. By combining the two companies?

technologies, AcouSort and GenSensor aim to automate cell capture and clean-up prior to molecular analysis. Initially, the collaboration will be focused on integration of AcouTrap units with GenSensor?s device as well as development of a new generation of devices dedicated to bioprocess monitoring and additional data collection regarding the isolated samples. In a future commercial phase, AcouSort will provide its AcouTrap units to GenSensor as OEM components.